The Mechanism and Potential Therapeutic Effects of Cyclosporin, Cyclophilin, Probiotics and Syndecan-1 in an Animal Model of Inflammatory Bowel Disease

<b>Background:</b> Inflammatory bowel diseases (IBDs) have several treatment modalities including immunoregulators, like cyclosporine A, an immunosuppressant that interacts with cytoplasmic cyclophilin A, and probiotics. <b>Aims:</b> This study explored and compared the possible role of syndecan-1 i...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Laura Dosh, Francesca Rappa, Abdo Jurjus, Gaelle Karam, Roaa Lezeik, Jad El Masri, Fabio Bucchieri, Angelo Leone, Rosalyn Jurjus
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-01-01
Colecção:	Pharmaceutics
Assuntos:	cyclosporine A cyclophilin A probiotics IBD inflammation syndecan-1
Acesso em linha:	https://www.mdpi.com/1999-4923/16/1/130
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!